VIOXX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vioxx, and when can generic versions of Vioxx launch?
Vioxx is a drug marketed by Merck and is included in two NDAs.
The generic ingredient in VIOXX is rofecoxib. There are two drug master file entries for this compound. Additional details are available on the rofecoxib profile page.
Summary for VIOXX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 115 |
Patent Applications: | 3,337 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VIOXX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for VIOXX
US Patents and Regulatory Information for VIOXX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | VIOXX | rofecoxib | SUSPENSION;ORAL | 021052-001 | May 20, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Merck | VIOXX | rofecoxib | TABLET;ORAL | 021042-002 | May 20, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Merck | VIOXX | rofecoxib | SUSPENSION;ORAL | 021052-002 | May 20, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Merck | VIOXX | rofecoxib | TABLET;ORAL | 021042-001 | May 20, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Merck | VIOXX | rofecoxib | TABLET;ORAL | 021042-003 | Feb 25, 2000 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VIOXX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | VIOXX | rofecoxib | SUSPENSION;ORAL | 021052-002 | May 20, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Merck | VIOXX | rofecoxib | SUSPENSION;ORAL | 021052-001 | May 20, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Merck | VIOXX | rofecoxib | SUSPENSION;ORAL | 021052-001 | May 20, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Merck | VIOXX | rofecoxib | TABLET;ORAL | 021042-001 | May 20, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Merck | VIOXX | rofecoxib | TABLET;ORAL | 021042-001 | May 20, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Merck | VIOXX | rofecoxib | TABLET;ORAL | 021042-002 | May 20, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Merck | VIOXX | rofecoxib | SUSPENSION;ORAL | 021052-002 | May 20, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VIOXX
See the table below for patents covering VIOXX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
New Zealand | 267386 | PHENYL SUBSTITUTED HETEROCYCLES, PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF | ⤷ Try a Trial |
Israel | 126899 | COMPOSITIONS FOR A ONCE A DAY TREATMENT OF CYCLOOXYGENASE-2 MEDIATED DISEASES | ⤷ Try a Trial |
Romania | 115354 | COMPUSI FENILHETEROCICLICI, PROCEDEE PENTRU PREPARAREA ACESTORA, INTERMEDIAR DE PREPARARE, COMPOZITIE FARMACEUTICA SI METODA PENTRU TRATAMENTUL UNEI AFECTIUNI INFLAMATORII (PHENYL-HETEROCYCLIC COMPOUNDS, PROCESSES FOR PREPARING SAID COMPOUNDS AND PREPARATION INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING AN INFLAMATORY DISEASE) | ⤷ Try a Trial |
Portugal | 828724 | ⤷ Try a Trial | |
Latvia | 12209 | AR FENILGRUPU AIZVIETOTI HETEROCIKLI KĀ CIKLOOKSIGENĀZES-2 INHIBITORI (PHENYL HETEROCYCLES AS CYCLOOXYGENASE-2 INHIBITORS) | ⤷ Try a Trial |
Germany | 69410092 | ⤷ Try a Trial | |
Australia | 1269495 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |